PUBLISHER: QYResearch | PRODUCT CODE: 1860013
PUBLISHER: QYResearch | PRODUCT CODE: 1860013
The global market for Animal Model Services was estimated to be worth US$ 3627 million in 2024 and is forecast to a readjusted size of US$ 5773 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.
Animal model is a living, non-human animal used during the research and investigation of human disease, for the purpose of better understanding the disease without the added risk of harming an actual human being during the process. Animal models have been used to address a variety of scientific questions, from basic science to the development and assessment of novel vaccines, or therapies. The use of animals is not only based on the vast commonalities in the biology of most mammals, but also on the fact that human diseases often affect other animal species. It is particularly the case for most infectious diseases but also for very common conditions such as Type I diabetes, hypertension, allergies, cancer, epilepsy, myopathies and so on. Not only are these diseases shared but the mechanisms are often also so similar that 90% of the veterinary drugs used to treat animals are identical or very similar to those used to treat humans.
The animal model services market is in a structural growth phase driven by multiple converging long-term trends. Pharmaceutical and biotech companies increasingly rely on customized, highly predictive in-vivo models to shorten development timelines and improve candidate translation; concurrently, maturation of gene-editing, humanized models and complex comorbidity models enables providers to deliver more clinically relevant solutions and capture premium service value. Moreover, heightened regulatory scrutiny and safety evaluation requirements for advanced therapeutics (e.g., cell and gene therapies) place animal model services at the core of preclinical compliance and risk management, generating durable demand for established vendors and end-to-end CROs.
Beneath the opportunities lie systemic risks: intensifying ethical and animal-welfare regulations and greater public scrutiny increase approval complexity and compliance costs; the live animal supply chain's sensitivity around strain purity, SPF status and biosafety means any supply disruption or quality event can cause major experimental delays and reputational harm; additionally, alternative technologies (organoids, organ-on-a-chip, advanced in-vitro systems) are maturing in certain use cases and alter demand boundaries for lower-complexity applications. For companies, investments in compliance, risk mitigation and sustainable operations are now central determinants of long-term competitiveness.
Downstream demand is evolving toward both higher-complexity needs and increased outsourcing. Large pharmaceutical firms and fast-growing biotech companies prefer to outsource complex models to CROs with platform capabilities and quality assurances to reduce fixed costs and improve reproducibility, while academic groups and early-stage teams demand standardized, reproducible models and comparable datasets-creating opportunities for model standardization services and biorepository partnerships. Regionally, rising R&D investment in emerging markets drives rapid local demand for high-quality animal model services, favoring providers that can deliver locally while meeting international compliance standards.
This report aims to provide a comprehensive presentation of the global market for Animal Model Services, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Animal Model Services by region & country, by Type, and by Application.
The Animal Model Services market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Animal Model Services.
Market Segmentation
By Company
Segment by Type
Segment by Application
By Region
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Animal Model Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Animal Model Services in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Animal Model Services in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.